Premium
Influence of Healing Period Upon Bone Turn Over on Maxillary Sinus Floor Augmentation Grafted Solely with Deproteinized Bovine Bone Mineral: A Prospective Human Histological and Clinical Trial
Author(s) -
Wang Feng,
Zhou Wenjie,
Monje Alberto,
Huang Wei,
Wang Yueping,
Wu Yiqun
Publication year - 2017
Publication title -
clinical implant dentistry and related research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.338
H-Index - 85
eISSN - 1708-8208
pISSN - 1523-0899
DOI - 10.1111/cid.12463
Subject(s) - maxillary sinus , medicine , dentistry , implant , biopsy , bone healing , bone grafting , sinus (botany) , surgery , pathology , botany , biology , genus
Abstract Purpose To investigate the influence of maturation timing upon histological, histomorphometric and clinical outcomes when deproteinized bovine bone mineral (DBBM) was used as a sole biomaterial for staged maxillary sinus floor augmentation (MSFA). Materials and methods Patients with a posterior edentulous maxillary situation and a vertical bone height ≤ 4 mm were included in this study. A staged MSFA was carried out. After MSFA with DBBM as a sole grafting material, biopsy cores were harvested with simultaneous implant placement followed by a healing period of 5, 8, and 11 months, respectively. Micro‐CT, histologic and histomorphometric analyses were performed. Results Forty‐one patients were enrolled and 38 bone core biopsies were harvested. Significantly greater BV/TV was observed between 5‐ and 8‐month healing from micro‐CT analysis. Histomorphometric analyses showed the ratio of mineralized newly formed bone increased slightly from 5 to 11 months; however, no statistically significant difference was reached ( p = .409). Residual bone substitute decreased from 37.3 ± 5.04% to 20.6 ± 7.45%, achieving a statistical significant difference from of 5 up to 11 months ( p < .01). Moreover, no implant failure, biological or technical complication occurred after 12‐month follow‐up of functional loading. Conclusion DBBM utilized as sole grafting material in staged MSFA demonstrated to be clinically effective regardless of the healing period. Histomorphometrical and micro‐CT assessments revealed that at later stages of healing (8 and 11 months) there is a higher proportion of newly‐bone formation compared to earlier stages (5 months). Moreover, the longer the maturation period, the substantially lesser remaining biomaterial could be expected. Even though, these facts did not seem to negatively impact on the implant prognosis 1‐year after loading.